Federica Trombetta

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Recent advances in high-throughput sequencing technologies have made ex-ome sequencing to be an outstanding tool for finding disease associated mutations at a relatively low cost. However, it is a non-trivial task to transform the vast amount of sequence data into meaningful variants to improve disease understanding. Several challenges arise when dealing(More)
  • 1